South Korean pharmaceutical company Genuone Sciences has recently formed a partnership with Vietnam’s pharmaceutical manufacturer Imexpharm in a strategic movement to expand its presence in Southeast Asian markets. This collaboration is expected to develop the manufacturing and distribution of vital medications for cardiovascular and diabetes-related diseases in Vietnam, offering hope to millions grappling with these chronic ailments.
The partnership will transform business dealings, representing a strategic advancement towards a healthier future for Vietnam. By transferring technology for seven essential pharmaceutical products, Genuone Sciences empowers Imexpharm to produce and supply medications crucial in combating prevalent health issues in the region. CEO of Genuone Sciences stressed the significance of this partnership in facilitating the company’s penetration into the dynamic Vietnamese market, underscoring their dedication to global health and well-being.
Imexpharm is one of the leading pharmaceutical manufacturers in Vietnam, with four manufacturing clusters across the country. As a part of the partnership, Genuone Sciences will support the entire production, supply, and distribution chain of Imexpharm, increasing the supply of high-quality medicines in the country. The collaboration is also in line with Vietnam’s National Strategy for Pharmaceutical Development towards 2030, focusing on promoting healthcare infrastructure.
(Source: BNN)